Acute kidney injury (AKI) is an important clinical problem that is associated with adverse short- and long-term outcomes. Studies published in 2019 provide new insights into the staging, risk stratification and subphenotyping of AKI as well as the adverse effects of AKI on the heart.
Key advances
The Kidney Disease: Improving Global Outcomes (KDIGO) definitions of stage 1 acute kidney injury (AKI) based on absolute versus relative changes in serum creatinine levels were associated with different outcomes in a retrospective cohort study1, highlighting the potential need for revisions to current AKI definitions.
Urinary Dickkopf-related protein 3 is a potential pre-operative biomarker for risk of AKI following elective cardiac surgery2.
An unbiased discovery method can identify distinct pathophysiological subphenotypes of septic AKI; these subphenotypes had differential treatment responses in a post hoc analysis of clinical trial data5.
A deep learning approach using electronic health record data can identify patients at high risk of AKI8.
In a mouse model, AKI results in direct cardiac injury and dysfunction9.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sparrow, H. G. et al. Disparate outcomes observed within Kidney Disease: Improving Global Outcomes (KDIGO) acute kidney injury stage 1. Kidney Int. 95, 905–913 (2019).
Schunk, S. J. et al. Association between urinary Dickkopf-3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: an observational cohort study. Lancet 394, 488–496 (2019).
Zarbock, A. et al. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA 313, 2133–2141 (2015).
Koyner, J. L. et al. Adjudication of etiology of acute kidney injury: experience from the TRIBE-AKI multi-center study. BMC Nephrol. 15, 105 (2014).
Reilly, J. P., Calfee, C. S. & Christie, J. D. Acute respiratory distress syndrome phenotypes. Semin. Respir. Crit. Care Med. 40, 19–30 (2019).
Bhatraju, P. K. et al. Identification of acute kidney injury subphenotypes with differing molecular signatures and responses to vasopressin therapy. Am. J. Respir. Crit. Care Med. 199, 863–872 (2019).
Russell, J. A. et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N. Engl. J. Med. 358, 877–887 (2008).
Tomasev, N. et al. A clinically applicable approach to continuous prediction of future acute kidney injury. Nature 572, 116–119 (2019).
Selby, N. M. et al. An organizational-level program of intervention for AKI: a pragmatic stepped wedge cluster randomized trial. J. Am. Soc. Nephrol. 30, 505–515 (2019).
Fox, B. M. et al. Metabolomics assessment reveals oxidative stress and altered energy production in the heart after ischemic acute kidney injury in mice. Kidney Int. 95, 590–610 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Huang, CT., Liu, K.D. Exciting developments in the field of acute kidney injury. Nat Rev Nephrol 16, 69–70 (2020). https://doi.org/10.1038/s41581-019-0241-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41581-019-0241-5